Monocentric Study, Phase III, for Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Tina Gel Sweet Flower

Sanofi0 个研究点目标入组 31 人开始时间: 2015年3月25日最近更新: 2015年3月30日

试验速览

暂无简介。

•Healthy female volunteers; aged between 10 and 20 years old; intact skin in the area where the test product will be applied; willingness in following the study procedures; to be able to attend the study visits;
•Are the trial subjects under 18? yes
•Number of subjects for this age range: 27
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 4
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•- Pregnancy or risk of pregnancy;
•- Lactation;
•- Use of anti-inflammatory and / or immunosuppressive drugs in the previous month of the study enrollment;
•- Use of topical medications in the area where the test product will be applied;
•- Active skin or gynecological pathologies that may interfere in the study evaluation;
•- History of allergic diseases in the region where the test product will be applied;
•- Atopic or allergic history.

发起方